Changes in connective tissue in patients with pelvic organ prolapse-a review of the current literature by Kerkhof, M.H. et al.
REVIEW
Changes in connective tissue in patients with pelvic organ
prolapse—a review of the current literature
M. H. Kerkhof & L. Hendriks & H. A. M. Brölmann
Received: 24 June 2008 /Accepted: 22 September 2008 / Published online: 15 October 2008
# The Author(s) 2008. This article is published with open access at Springerlink.com
Abstract Little is known about the pathophysiology of
pelvic organ prolapse (POP). In 1996, Jackson presented a
hypothesis on pelvic floor connective tissue that tried to
explain the development of POP on a molecular level. The
objective of this review is to test the hypothesis against
recent literature. The method used was a review of literature.
The association between POP and connective tissue metab-
olism is well established. However, the causality of this
association is unclear. The characteristics of the pelvic floor
connective tissue of POP patients relate to tissue repair. To
resolve the question of cause and effect, the role of
fibroblasts in producing the extracellular matrix should be
clarified. With these data, the use of autologous or allogenic
stem cells in the treatment of POP may come in sight. Recent
literature supports the hypothesis of Jackson but does not
resolve long-standing questions on the aetiology of POP.
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Abbreviations
POP Pelvic organ prolapse
ATFP Arcus tendineus fasciae pelvis
ECM Extracellular matrix
USL Uterosacral ligaments
UsR Uterosacral ligament resilience
AGE Advanced glycated endproduct
MMP Matrix metalloproteinases
TIMP Tissue-derived inhibitors of metalloproteinases
LOX Lysyl oxidases
ET-1 Endothelin-1
ER Estrogen receptor
Introduction
Pelvic organ prolapse (POP) is a global health problem,
affecting adult women of all ages. It decreases their quality
of life considerably [1–3]. POP is one of the most common
reasons for gynaecological surgery in women after the
fertile period. The failure rate is relatively high: An
estimated 30% of women require re-operation [3]. Despite
the high incidence of POP, little is known about the
underlying pathophysiolgy of POP. Multiparity, old age,
overweight, chronic straining and obstructive lung diseases
are the most important risk factors [4, 5]. However, also
nulliparous women without any risk factors may develop
POP. Therefore, a genetic predisposition may play a role as
well [6–8]. When a mother has POP, the relative risk for the
daughter of developing POP is 3.2. With a sister’s positive
medical history, this relative risk is 2.4 [9]. In combination
with the finding that women with joint hypermobility have
a significant higher prevalence of POP [10], it is hypoth-
esised that a connective tissue factor is involved.
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In 1996, Jackson found that patients with a descent of
the cervix to, or beyond the introitus, with associated
cystocele, have a reduced collagen content, with a relatively
high content of immature collagen cross-links compared to
non-POP patients. This newly formed collagen is degraded
more easily than older glycated material, resulting in a
decrease of collagen content, leaving behind glycated
collagen resulting in tissue with an impaired mechanical
strength [11]. He also found an increase in metalloprotei-
nase activity, suggesting an increased degradation of
collagen in patients with POP. He concludes that the bulk
of this deficient glycated old collagen, which is brittle and
susceptible to rupture, is an important aetiologic factor in
POP. Up till now, the connective tissue metabolism is
assessed by biochemical evaluation. The role of fibroblasts
that produce the molecules in the extracellular matrix, such
as collagen and elastin, needs further elucidation. It has
been suggested to treat POP with autologous stem cells
[12]. These stem cells are stimulated to differentiate into
fibroblast-like cells producing collagen and can be seeded
on biocompatible material serving as a “bioactive scaffold”.
Before doing so, it is important to know if there is a
defective collagen metabolism at all caused by an error in
the fibroblast, and if so, if this is the result of a genetic or an
acquired defect.
The objective of this review is to summarise our current
understanding of changes in pelvic floor connective tissue
in women with POP compared to women without POP.
Studies concerning collagen metabolism in POP patients
will be reviewed in the light of Jackson’s hypothesis [13].
Based on subsequent literature, we will test this hypothesis
against the latest facts. We will also make recommendations
for future research. Ultimately, this knowledge may lead to
preventive measures that could eliminate or delay the onset
of prolapse and improve surgical treatment.
Materials and methods
The primary investigator and a clinical librarian searched
the computerised databases MEDLINE and EMBASE up to
2008, using terms such as “prolapse”, “uterine prolapse”,
“cystocele”, “rectocele”, “pelvic organ support”, “urinary
incontinence”, “connective tissue”, “collagen”, “hydroxy-
proline”, “tropocollagen”, “procollagen”, “protocollagen”,
“extracellular matrix”, “elastic tissue”, “supportive tissue”,
“extracellular matrix proteins”, “tissue inhibitor of metal-
loproteinases”, “matrix metalloproteinases” and “collage-
nases”. Not only free text terms but also Mesh terms were
used. Only data published in full article form were
included. Additionally, articles were obtained by reviewing
reference lists of pertinent studies and reviews. Also, the
Web of Science was searched for “citing papers” and
“related articles”. No articles written in languages other
than English provided additional information.
Anatomy and function of the vagina and supportive
connective tissue
The pelvic floor is the caudal confinement of the abdominal
cavity, which contains the abdominal viscera. In the days
when we were quadrupeds, the pelvic floor was supposed
to wag the tail. Now, in erect humans, its function is to
prevent the viscera from “falling out” and to enable sexual
intercourse, birth and the deliberate passage of stools and
urine. In case of a sudden increase of the abdominal pressure,
e.g. during coughing, all the muscles confining the abdominal
cavity will contract. They create a counterforce that maintains
the bodily shape. The pelvic floor is lifted at contraction and
the genital hiatus is closed, preventing not only the uterus and
vagina but also the intestines from being pushed out. If the
pelvic floor has weakened, e.g. during vaginal delivery,
the hiatus may not fully close anymore at contraction of
the levator muscle. The counterforce will not come into
effect, and POP may occur.
A second line of defence is the vaginal support from the
connective tissue attachments between the vagina and the
pelvic sidewall and levator ani muscles. The supportive
connective tissue is a continuous, interdependent sheet,
which supports the vagina and the pelvic organs. Based on
post mortem data, Delancey [14] described pelvic floor
support at three levels. Level I includes the uterosacral
ligaments. The middle part of the vagina (endopelvic
fascia) is attached laterally to the arcus tendineus fasciae
pelvis (ATFP) and the superior fascia of the levator ani
muscles (level II). In the lower third of the vagina, the wall
is directly attached to the surrounding structures, the
perineal membrane and the perineal body (level III). This
suspensory system prevents the uterus and vagina from
falling out while the hiatus is opened. If the resilience of the
connective tissue decreases with age, the ligaments may
finally give way, and POP may develop [15].
Pelvic floor connective tissue
The vaginal wall is composed of four layers: a superficial
layer of stratified squamous epithelium, a subepithelial dense
connective tissue layer, composed primarily of collagen and
elastin, a layer of smooth muscle referred to as the
muscularis and an adventitia, which is composed of loose
connective tissue. The vaginal subepithelium and muscularis
together form a fibromuscular layer beneath the vaginal
epithelium, providing longitudinal and central support.
The connective tissue underlying the vagina contains
relatively few cells: Beside fat cells and mast cells, mainly
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fibroblasts are found, producing components of the extra-
cellular matrix (ECM). The ECM contains fibrillar compo-
nents (collagen and elastin) embedded in a non-fibrillar
ground substance. This ground substance consists of non-
collagenous glycoproteins, proteoglycans and hyaluronan.
In addition, with the exception of the ATFP, these tissues
contain a significant amount of smooth muscle cells [16].
The fibrillar component is thought to contribute the most to
the biomechanical behaviour of these tissues. The quantity
and quality of collagen and elastin are regulated through
a precise equilibrium between synthesis, maturation and
degradation. This process results in a dynamic process of
constant remodelling.
Collagen synthesis
In 1954, Ramachandran and Kartha [17] discovered the
triple helical structure of collagen. In the endoplasmatic
reticulum, α chains are formed, followed by posttransla-
tional modifications of proline and lysine residues. Each
collagen molecule is made of a precise combination of three
α-polypeptide chains. Depending on the collagen type, the
three α-polypeptide chains vary. The three helices are
twisted together into a triple helix, stabilised by numerous
hydrogen bonds. There is some covalent cross-linking within
the triple helices and a variable amount of covalent cross-
linking between collagen helices, resulting in tissue-residing
collagen of different maturity.
Once the triple helix called procollagen is formed
intracellularly, it is secreted into the extracellular space.
Tropocollagen molecules are formed by the action of
carboxy-terminal and amino-terminal peptidases. The tro-
pocollagen molecules undergo self-assembly into collagen
fibrils, which in turn associate to form fibres and fibre
bundles (Fig. 1). The shape and behaviour of a tissue are
determined in part by the correct positioning of collagen
fibrils within a fibre and fibres within a matrix.
There are 28 types of collagen. The fibrillar collagens I,
III and V, present in the vagina, and its supportive tissues
are thought to be the principal determinants of soft tissue
strength. Collagen I fibres are universally present and are
flexible and offer great resistance to tension. Collagen III is
predominant in tissues that require increased flexibility and
distension and that are subject to periodic stress [18]. It is
the primary collagen subtype in vagina and supportive
tissues. Collagen III is the major collagen in skin at birth
before it is replaced by collagen I later in life. Both type I and
type III are found in granulation tissue during wound repair
[19, 20]. Collagen V is of minor quantitative importance. It
forms small fibres with very low tensile strength and has
Fig. 1 Collagen biosynthesis.
Collagen is synthesised as pre-
pro-α-chains (1). Following
translocation into the rough en-
doplasmic reticulum, the signal
peptides are removed, and the
individual procollagen α-chains
will associate through the C-
propeptides. After multiple steps
of posttranslational modifica-
tions, which include the hy-
droxylation of specific lysine
(Lys) and proline (Pro) residues
as well as the glycosylation of
hydroxylysyl residues (2), the
triple helix propagates from the
C- to N-terminus. The procolla-
gen is excreted and is converted
extracellularly into collagen by
cleaving the propeptides (3).
Subsequently, collagen mole-
cules assembly into ordered
fibrils (4), which are finally
stabilised by the formation of
inter- and/or intramolecular
cross-links (5)
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been found to be also important in wound healing and
fibrillogenesis [21]. The role of collagen V in the vagina
and supportive tissue has not been elucidated yet.
Collagen I copolymerises with collagen III and V to form
fibrils with controlled diameters. These fibrils influence the
biomechanical characteristics of a given tissue [21]. An
increase in collagen III and V decreases the mechanical
strength of connective tissue by decreasing fibre size [22].
It is generally agreed that a higher I/III ratio in the ligament
is indicative of greater strength, whereas a lower ratio may
result in tissue laxity.
Maturation and physiological ageing of collagen
Age is a risk factor for POP. In the POSST study, there was
a 10% increased risk of POP for each decade of life [23].
Olsen et al. [3] found that the cumulative incidence of
primary operation for POP and incontinence increased from
0.1% in the age group 20–29 up to 11.1% in the age group
70–79.
Reay Jones et al. [15] assessed the Uterosacral ligament
Resilience (UsR) by tensiometry in patients with and
without POP to determine whether it influenced uterine or
pelvic floor mobility or whether it varied with age, vaginal
delivery, menopause or histological variations in the ligament.
He found that the UsR was significantly reduced (P=0.02) in
symptomatic POP. There was a significant decrease in UsR
with menopause (P=0.009) and older age (P=0.005),
suggesting that where pelvic floor muscles are weakened, a
decrease in pelvic connective tissue resilience—related to the
age and menopause—may facilitate progression to symp-
tomatic POP.
Two mechanisms of maturation of collagen have been
identified. The first involves the enzymatically controlled
lysine aldehyde cross-links. The initial enzymatic controlled
divalent cross-links dehydro-hydroxy lysinonorleucine and
hydroxylysinoketo-norleucine are converted to stable triva-
lent cross-links, histidino-hydroxylysinonorleucine and
hydroxylysyl-pyridinoline, as the tissue matures [24]. The
relative proportion of the initial divalent cross-links to
mature cross-links enables an assessment of the maturation
of the tissue. The mechanism of creating strength of the
collagen by interfibrillar cross-links is currently under
investigation.
Secondly, the mature, slowly metabolising collagen is
susceptible to the so-called non-enzymatic cross-linking,
also known as glycation or Maillard reaction. It involves
the fairly random addition of glucose to the collagen, as the
turnover of collagen is generally rather low. The products
of this glycation ultimately react further to form intermo-
lecular cross-links. It has been well established that these
advanced glycated endproducts (AGEs) of collagen accu-
mulate with age (Fig. 2). This mechanism is the major
cause of substantial dysfunction of the collagenous tissues
and is responsible for the complications of connective
tissues seen at older age. The “overmature” collagen is
stiffer and therefore more fragile than the collagen that
exhibit only enzymatic cross-links [24, 25]. The glycation
of other proteins involves the same mechanisms. But the
long biological half-life of collagen ensures that it plays an
important role in ageing. The nature and relative impor-
tance of the cross-links formed in vivo, in comparison to
those reported formed in vitro with model compounds, still
needs to be established as the structure of only a few AGEs
has been established.
With the knowledge of changes of collagen with age,
more research of POP, especially in young women, will
elucidate the underlying pathophysiology of the disease.
Degradation of collagen
The balance between synthesis and degradation of collagen
is important for maintaining tissue integrity and tensile
strength during continuous tissue remodelling. Degradation
depends upon the combined activity of matrix metal-
loproteinases (MMP) and their regulation of release,
activation or sequestration of growth factors, growth factor
Fig. 2 Collagen maturation. As the tissue matures, immature collagen
fibres with divalent cross-links (1) are enzymatically converted to
mature collagen fibres with stable trivalent cross-links (2). The
mature, slowly metabolising collagen is susceptible to non-enzymatic
cross-linking, also known as glycation or Maillard reaction with the
formation of advanced glycation endproducts (3)
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binding proteins, cell surface receptors and cell–cell
adhesion molecules [26]. MMPs are being synthesised
intracellularly and secreted as pro-enzymes into the
extracellular space, which requires conversion to the active
form for enzymatic activity. Twenty-three different mem-
bers of the MMP family have been identified in humans.
They all can degrade one or more extracellular matrix
components, however, with different specificities. The
interstitial and neutrophil collagenases (MMP-1, MMP-8,
MMP-13) are capable of cleaving fibrillar collagen, while
the gelatinases (MMP-2 and MMP-9) degrade the resulting
denatured peptides. Acid cathepsins depolymerise collagen
fibres by cleaving near cross-link sites. The combined
action of these enzymes is capable of degrading all
components of the extracellular matrix.
To limit connective tissue degradation, the activity of
MMPs is regulated by modulation of pro-enzyme produc-
tion [27]. Overdegradation is also regulated by endogenous
inhibitors: serum-borne inhibitors and the tissue-derived
inhibitors of metalloproteinases (TIMPs). They bind stoi-
chiometrically to MMPs to inhibit their activity. TIMP-1, as
well as TIMP-3, binds to MMP-1 and MMP-9; TIMP-2
binds to MMP-2 [28, 29]. Recently, those that have been
formed in vitro have shown that active MMPs can also be
inactivated spontaneously by degradation into smaller
fragments. This process is referred to as autocatalysis
[30, 31].
Elastin
The mechanical properties of tissues are also dependent on
the proportion of elastin, an insoluble polymer that is
formed by the assembly of tropo-elastin monomers fol-
lowed by catalysis of cross-link formation by lysyl oxidases
(LOX). Elastin allows the tissue to stretch and return to its
original shape without energy input [32]. This property of
resilience is presumed important for reproductive tissues. It
accommodates the enormous expansion in pregnancy and
involution after parturition. Production of elastin is unique
among connective tissue proteins. In most organs, elastin
biosynthesis is limited to a brief period of development.
The assembly of elastic fibres is complete by maturity when
tropo-elastin synthesis ceases. In undisturbed tissues, elastic
fibres produced in the third trimester of foetal life last the
rest of life [33]. In the female reproductive tract, however,
elastic fibre turnover appears to be continuous. Recently, it
is found that LOX is essential for elastic fibre homeostasis
in many tissues, including the female pelvic organs. Mice
lacking LOXL1 are unable to synthesise elastin polymers in
adult tissue, whereas collagen synthesis appears to proceed
normally. These mice also fail to replenish mature elastin
fibres in the reproductive tract after parturition. They
develop spontaneous prolapse [33, 34]. Fibulin-5, which
is an elastic binding protein crucial for elastic fibre
assembly [35], is believed to act as a bridge between cells
and tropo-elastin for effective cross-linking and assembly
of tropo-elastin into mature elastic fibres. Increased
synthesis of tropo-elastin and fibulin-5 may be necessary
to counteract for disruption of elastic fibres and to
regenerate elastic fibres in the vaginal wall. In fibulin-5
knock-out mice, POP was similar to that in primates,
suggesting that synthesis and assembly of elastic fibres are
crucial for recovery of pelvic organ support after damage.
Disordered elastic fibre homeostasis seems to be a primary
event in the pathogenesis of POP in mice [36].
Pelvic floor connective tissue in POP
Collagen synthesis and subtypes in POP
Studies on changes in the quantity and ratios of subtypes of
collagen produced inconclusive data. Both increase and
reduction of total collagen content of vaginal and pelvic
floor supportive tissues in patients with POP have been
reported (Table 1). Different methods of quantification of
collagen content and also the lack of information on tissue
histology and biopsy site of the vagina or supportive tissue
that was analysed make direct comparison between studies
difficult. Table 1 shows that tissue obtained from uterine
ligaments of patients with POP seems to show a decreased
total collagen content [11, 37–39] with a higher concentra-
tion of collagen III [40–43] irrespective of age or parity. An
increased collagen III content may suggest tissue repair
after overstretching of the supportive connective tissue of
the pelvic floor. Moalli et al. [41] also found a significantly
increased expression of active MMP-9 in women with
POP relative to controls. An increase in collagen III in
combination with an increase in active MMP-9 is typical
of tissue that is remodelling after injury or a tissue that is
remodeling to accommodate a progressively increasing
mechanical load [44]. A higher expression of tenascin, an
extracellular matrix glycoprotein that reappears around
healing wounds [42], supports this theory.
Cross-linking of collagen in POP
There is more to collagen than just the total amount and the
subtypes. Barbiero et al. [45] performed a qualitative analysis
of type I collagen in the parametrium of patients with and
without POP. It was demonstrated that the parametrium
consists of shorter, thinner and more disorderly arranged
collagen fibres in patients with uterine prolapse compared to
healthy controls.
The maturity of the tissue depends on the relative
proportion of the divalent cross-links to the mature
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Table 1 Collagen analysis in biopsy specimens from vaginal or supportive tissue in women with or without POP
Study Target population and
sample size
Tissue analysed Analytic methods Findings: patients with POP
compared to controls
Makinen 1987 [61] 5 women with uterine
prolapse
Vaginal fascia Collagen I mRNA in fibroblasts
cultured from vaginal biopsies
No difference in collagen I
mRNA
5 controls
Jackson 1996 [13] 8 premenopausal
women with POP
Vaginal epithelium Hydroxyproline assay, protein
analysis of collagen a chains
Decreased total collagen No
difference in ratio collagen I/III
10 controls
Kökçü 2001 [58] 24 premenopausal
women with POP
Vaginal fascia in
precervical region,
cardinal, uterosacral
and round ligaments
Histology with haematoxylin and
eosine, Gomori’s trichome and
Verhoeff elastic stains followed
by light microscopy
Increased total collagen
21 controls
Liapis 2001 [96] 34 women with SUI
and POP
Paravaginal fascia and
the uterosacral
ligaments
Immunohistochemical analysis
and light microscopy
Decreased collagen III in SUI and
POP, no significant difference in
women with POP alone
compared with controls
32 women with POP
28 controls
Takano 2002 [38] 10 premenopausal
women with POP
Lateral parametrium
and vaginal apex
Histology with picrosirius Decreased collagen in lateral
parametrium in POP in women
with POP compared with
controls
23 postmenopausal
women with POP
22 controls
Ewies 2003 [42] 33 women with POP Cardinal ligaments Histological confirmation
immunohistochemistry
Increased collagen III, but
suppressed effect by HT25 controls
Goepel 2003 [97] 15 postmenopausal
women with POP
Periurethral ligaments Immunohistochemistry and light
microscopy
Decreased collagen I, III and VI
in women with SUI
14 postmenopausal
women with POP and
SUI
Decreased total collagen in
women with POP
Moalli 2004 [40] 10 premenopausal
women
ATFP Laser scanning confocal
microscopy and
immunofluorescence
Decreased collagen I in
postmenopausal women
Increased collagen I in
postmenopausal women with HT
5 postmenopausal
women
Decreased ratio collagen I/III in
postmenopausal women and
increased with HT12 postmenopausal
women with HT
Wong 2003 [39] 14 women with POP Uterine cervix Hydroxyproline assay Decreased total collagen
17 controls
Soderberg 2004 [11] 22 women with POP Paraurethral ligaments Hydroxyproline assay Decreased total collagen in
women with POP <53 years; no
difference in POP and controls
>53 years
13 women without
POP
Gabriel 2005 [83] 25 women with POP Uterosacral ligaments Immunohistochemistry Increased collagen III
16 controls
Moalli 2005 [41] 31 premenopausal
women: 16 women
with POP, 15 controls
Full thickness vaginal
apex
Histology, laser scanning
confocal microscopy and
immunofluorescence, gelatin
zymography
Increased total collagen in
premenopausal women with
POP and postmenopausal
women without HT
46 postmenopausal
women with POP: 23
women on HT, 23
women without HT
Decreased total collagen in
women with POP and SUI
Increased collagen III in women
with POP
No difference in collagen I and V
in women with POP
SUI stress urinary incontinence, HT hormone therapy
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(trivalent) cross-links. Furthermore, mature, slowly metab-
olising collagen is susceptible to non-enzymatic glycation
and some of these AGEs, such as pentosidine, are
additional cross-linking compounds that may further inhibit
the turnover of collagen.
Jackson [13] showed that POP was associated with a
significant rise in the immature cross-link. The mature
pyridinoline cross-linking was not altered. Pentosidine was
increased significantly in the prolapse tissue, and pentosidine
concentrations increased with increasing age in both groups,
demonstrating that non-enzymatic glycation of collagen
occurs slowly over a long time. This greater pentosidine
concentration in prolapse tissue makes the tissue less
soluble than in controls, reflecting the maturity of the tissue
[46].
Only two studies describe the cross-linking of collagen
fibres in POP [11, 47]. However, both studies only analysed
a specific subset of cross-links, limiting their conclusions to
these subsets. Söderberg et al. [11] found a decrease in
extractability by pepsin digestion at young age in both
women with and without POP compared to older women.
This is an indicator of cross-links in the collagen molecule.
It is considered a physiological effect of normal ageing.
Chen et al. [47] analysed pyridinoline, the major mature
collagen cross-link in fascia, in anterior vaginal wall. There
was no difference between the incontinent women with
POP and the continent women without POP. This is in
accordance with the findings of Jackson [13].
Collagen degradation, matrix metalloproteinase and tissue
inhibitor of matrix metalloproteinase
The majority of studies on MMPs focus on synthesis (pro-
MMP or MMP messenger RNA (mRNA)). Although the
active form is the most relevant form with respect to tissue
degradation, the analysis of the entire expression profile of
these enzymes, including pro-enzyme, active and autocat-
alytic forms, should provide a more conclusive insight
[48, 49].
Jackson [13] suggested an increased metabolic turnover
of collagen, since MMP-2 and MMP-9 were significantly
higher in prolapse tissue than in normal tissue. He did not
assess the expression of other MMPs or the TIMPs. As
shown in Table 2, an increase in pro-MMP-2 and active
MMP-2 was confirmed by two other studies [43, 50].
Summarising the data of Table 2 concerning the activity of
MMP point to a condition in which the degradation of
connective tissue is accelerated in the vagina and the
supportive tissue of patients with POP by an increased
expression of pro- and/or active metalloproteinases in
combination with a decrease in TIMP-1 mRNA and active
TIMP-1 expression [47].
Table 2 Analysis of matrix metalloproteinases and tissue inhibitor of matrix metalloproteinase in biopsy specimens from vaginal or supportive
tissue in women with or without POP
Study Target population and
sample size
Tissue analysed Analytic methods Findings: patients with POP
compared to controls
Jackson 1996 [13] 8 premenopausal women
with POP and 10 controls
Vaginal
epithelium
Hydroxyproline assay Increase of pro MMP-2, active
MMP-2 and MMP-9
Chen 2002 [47] 7 women with POP and
SUI and 15 controls
Anterior vaginal
wall
Quantitative competitive
reverse transcription PCR
Decreased TIMP-1 mRNA and
increased MMP-1 mRNA
No difference in TIMP-2 and
TIMP-3 mRNA or MMP-2,
MMP-9
Moalli 2005 [41] 31 premenopausal women:
16 women with POP, 15
controls
Full thickness
vaginal apex
Histology, laser scanning
confocal microscopy and
immunofluorescence, gelatin
zymography
Increased active MMP-9 in
premenopausal women with POP
and in postmenopausal women
with HT
46 postmenopausal
women with POP: 23
women on HT, 23 women
without HT
No difference in the expression of
pro-MMP-2, active MMP-2 or
pro-MMP 9
Gabriel 2005 [43] 17 women with POP Uterosacral
ligaments
Immunohistochemistry Increased expression of MMP-2
18 controls No difference in expression of
MMP-1
Philips 2006 [50] 14 women with POP Uterosacral
ligaments and
vaginal
epithelial tissue
Immunohistochemistry In vaginal epithelium: increased
expression of pro-MMP-2
14 controls No difference in active MMP-2,
MMP-9 and TIMP-2
E2 estradiol, SUI stress urinary incontinence, HT hormone therapy
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Elastin metabolism in POP
The importance of elastic fibres in maintaining vaginal
support is demonstrated by genetic connective tissue
diseases like Marfan’s syndrome (mutations in fibrillin-
gene) and cutis laxa (mutation in elastin and fibulin-5
genes). An increased incidence of POP is seen in women
affected by these connective tissue diseases [51, 52].
Some changes in elastin expression in relation to POP
are reported (Table 3). But the ways by which elastin is
measured also vary: via mRNA level, precursor protein
levels or mature elastin levels. Elastin mRNA is a few steps
away from the actual elastin. Also, the protein precursor of
elastin, tropo-elastin, can be measured without actually
measuring the amount of mature elastin [48, 53]. A
common way to quantify mature elastin used by Jackson
is by indirectly measuring its cross-links with desmosine
[54]. This measurement could be inaccurate, however,
when studying a disease such as POP in which the cross-
linking process may be disrupted and desmosine concen-
tration is more reflective of diminished cross-linking than
the total amount of elastin [48]. The most direct and thus
appropriate way to measure elastin is by immunohisto-
chemistry [53].
Even though the techniques used to obtain the data vary
and thus provide inconclusive data, there is circumstantial
evidence that a deficient synthesis and degradation of
elastic fibres may be associated with POP [42, 53, 55–57].
The fibroblast in POP
If the collagen content in POP is changed, this may be
caused by differences in the number of fibroblasts (cellu-
larity) in the connective tissue [58, 59]. But, the quality, i.e.
functionality of the fibroblast, may also be important in the
pathogenesis of POP. There is some indication that the
contractibility of the vaginal (myo)fibroblasts is decreased
in POP patients, which may result in deficient collagen
[60]. In models of wound healing, skin myofibroblasts
control the contractile and strength of the tissue, which is
regulated by the so-called endothelin-1 (ET-1) system.
Poncet et al. [60] compared cultures of α-smooth muscle
actin-positive myofibroblasts that were established from
POP patients to myofibroblasts from primiparous women
with respect to their expression of the ET-1 system and
contractile properties. They found that spontaneous contrac-
tion of myofibroblasts from estrogen-treated women with
POP was significantly lower than from young primiparous
Table 3 Analysis of elastin in biopsy specimens from vaginal or supportive tissue in women with or without POP
Study Target population and
sample size
Tissue analysed Analytic methods Findings: patients with POP
compared to controls
Yamamoto 1997 [57] 4 postmenopausal
women with POP
Cultured fibroblasts
from cardinal
ligaments
mRNA by Northern blot analysis Decreased mRNA and tropo-
elastin production by fibroblast
4 controls Tropo-elastin by Western blot
analysis
Ewies 2003 [42] 33 women with POP Cardinal ligaments Histological confirmation
immunohistochemistry
Decreased elastin content
25 controls
Chen 2004 [55] 12 women with SUI and
or POP 15 controls
Periurethral vaginal wall Quantitative competitive-PCR
mRNA and confirmatory
Western blot analyses
Decrease in endogenous inhibitors
of elastases with increase in
elastolytic activity resulting in
decrease in elastin content
Goepel 2007 [56] 29 postmenopausal with
POP
Uterosacral ligaments Immunofluorescence microscopy
elastin/tenascin
Decreased elastin content,
increased tenascin content
30 controls
Karam 2007 [53] 33 women with POP Anterior vaginal wall Histological confirmation
immunohistochemistry
Decreased elastin content
10 controls
Klütke 2008 [98] 31 women with POP Uterosacral ligaments Desmosine by
radioimmunoassay; quantitative
real-time PCR mRNA levels of
LOX, LOXL1, LOXL2 and
(FIB-5)
Decreased desmosine content
29 controls Suppression of mRNA for LOX
and two LOX isoenzymes
Lin 2006 [99] 23 women with POP Anterior vaginal wall Immunohistochemistry No difference
15 controls
Jackson 1996 [13] 8 premenopausal
women with POP
Vaginal epithelium Desmosine by modified ion-
exchange method
No difference
10 controls
LOX lysyl oxidase, LOXL1 lysyl oxidase like-1; FIB-5 fibulin-5, SUI stress urinary incontinence
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women. Addition of exogenous endothelin-1 decreased the
spontaneous contraction of myofibroblasts, which is oppo-
site to observations in skin myofibroblasts.
Makinen et al. [61] studied the rates of collagen
synthesis and procollagen mRNA levels in cultured fascia
fibroblasts of patients with POP. They found that these
fibroblasts exhibited rates of collagen synthesis similar to or
slightly higher than those from age-matched controls. This
finding suggests that POP is not related to defects in the
capacity of vaginal fibroblasts to synthesise or process
procollagen. The existence of a possible qualitative change
in type I and or type III collagen could not be ruled out in
this study. There are no indications of mutations in the
various polypeptides in collagen type I and III. Mutations
could produce minor changes in collagen fibres that would
make connective tissue less able to withstand the stresses of
an individual lifespan and could explain predisposition to
common diseases affecting connective tissue.
With respect to the production of elastin, the elastin gene
expression and protein synthesis in fibroblasts derived from
cardinal ligaments of patients with POP is markedly lower
than in non-POP patients [57]. This may be a result of a
decreased expression of the wild-type p53 mRNA and wild-
type p53 protein in fibroblasts of women with POP. Cells
fail to enter quiescence (G0 phase) that may lead to a
decrease in synthesis and deposition of elastin.
The synthesis of components of the ECM by fibroblasts
is influenced by stretch. Whether it is cause or effect,
prolapsed tissue is stretched tissue. Ewies demonstrated
recently that mechanical stretch disturbs the fibroblasts’
ability to maintain the cytoskeleton architecture. The use of
estrogens did not reverse the process or protect the cells
from the effect of stretch, but significantly increased the
rate of fibroblast proliferation, suggesting their role in the
healing process [62].
These results suggests, in contrast to the findings of
collagen production, that functional changes in the fibroblasts
of the cardinal ligaments are involved in the mechanism of
prolapse development [57, 63, 64]. In relation to POP in
which tissue is stretched, it is demonstrated that mechanical
stretch disturbs the fibroblasts’ ability to maintain their
cytoskeleton architecture and we speculate that they may
disrupt ligamentous integrity and result in clinical prolapse.
The role of estrogen in collagen metabolism in POP
As estrogen deficiency is a known risk factor for POP [65],
estrogen replacement therapy traditionally has been used to
improve structural integrity of the pelvic tissue with
favourable effects on urinary incontinence[66–69]. Previ-
ously, estrogen receptors (ER) were identified in the nuclei
of connective tissue and of the smooth muscle cells of the
bladder trigone, urethra, vaginal mucosa, levator ani stromal
and uterosacral ligament. Two different subtypes have been
found in human cells: ER-α is the dominant receptor in the
adult uterus, whereas ER-β is expressed at high levels in
other estrogen-target tissues such as prostate, testis, ovary,
smooth muscle, vascular endothelium and immune system.
These receptors participate in maintaining the supportive
system of the pelvic by a.o. increasing synthesis or by
decreasing breakdown of collagen and other extracellular
matrix proteins [70]. Few studies have been done to assess
the tissue expression levels of sex steroid hormone
receptors in patients with POP. Lower estrogen receptor
expression in patients with POP have been found in
combination with lower serum concentrations of estrogen
[65, 71]. In contrast, higher sex steroid hormone receptor
expression in POP patients has also been described [72].
Several studies report an increase in the mRNA
expression for collagen I and III in estrogen replacement
therapy [30, 73, 74]. These findings suggest that estrogen
increases the turnover of connective tissues of the pelvic
floor. It is also suggested that estrogen restores the collagen
metabolism to a premenopausal state [41]. In a double-
blind, placebo-controlled trial with postmenopausal women
with urinary stress incontinence treated with estradiol
therapy, Jackson [13] found strong evidence for both new
synthesis and degradation. The immature cross-links were
increased, indicating newly synthesised collagen. However,
the ratio of type I/III collagen was unchanged in the
estradiol treated group, and the total collagen content was
significantly decreased. Also, an elevation of both the pro-
active and active forms of MMP-2 and MMP-9 in women
treated with estradiol compared to controls was found. This
resulted in a decrease in total collagen content [75]. Also, a
combination of upregulation of MMPs and suppression
of TIMP by estrogen resulted in an increase of ECM
breakdown [76].
Inhibition of MMP by estrogen therapy is also reported
[77, 78]. Zong et al. [49] found that only E2 combined with
progesterone decreased the active form of MMP-1, which
suggests that both hormones are necessary to maintain the
integrity of the female pelvic floor.
With respect to elastin, Moalli et al. [40] found no
differences between pre-, post- and postmenopausal women
on hormone therapy.
Estrogens and fibroblasts
17β-Estradiol may have a suppressive effect on prolifera-
tion of fibroblasts, derived from cardinal ligaments in
patients with POP. Therefore, 17β-estradiol may have a
role in inducing POP by negatively affecting the concen-
tration of fibroblasts in pelvic organ connective tissue [79].
Estrogen therapy, thus, induces turnover of collagen, but
the precise role of estrogen in collagen metabolism related
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to POP is still unclear. Data suggest an increased mRNA
expression of collagen type I and III as a reaction to
hormone replacement therapy, with a concomitant increased
synthesis of these collagen types. However, an increased
activity of MMP, resulting in an increase in collagen
degradation, is also reported. Whether sex steroid receptors
are a primary cause or a downstream effect of POP remains
unknown.
Discussion
The development of POP is multifactorial. Factors contrib-
uting to the development of POP can be divided into genetic
and acquired factors [1]. Genetics and race predispose a
certain population of women to POP. Inciting factors include
pregnancy and parity as well as myopathy and neuropathy.
Obesity, smoking, pulmonary disease and obstipation are
examples of POP-promoting factors. Patients with these risk
factors tend to develop POP in a higher frequency with
ageing and menopause as superimposing decompensation
factors.
Several studies have underlined the role of a strength
deficit of urogenital tissues, which is attributed to changes
in synthesis and degradation of different types of collagen
and elastin in POP development [80]. Also, the function of
supporting and contractile cells, the fibroblasts, may be
disturbed [60]. However, data on the changes in collagen
metabolism in patients with POP are conflicting. The
differences may partly be due to the analysis of different
target tissue in patients with POP. The tissue which
supports the vagina and the pelvic organs can be divided
into the suspensory system part (Delanceys’ level I and II)
and the supportive part (level III) [14, 81]. The quantity,
type and organisation of collagen, elastin and smooth
muscles cells vary within the different tissues [41]. Tissues
from all three levels were used to study the possible defects
in collagen metabolism in patients with POP without
defining and relating them to the type and stage of the
prolapse. Beside the variety in biopsy sites, the majority of
the studies do not define tissue histology, making it difficult
to determine exactly which portion (e.g. epithelium vs.
subepithelium) is being analysed. Histology of the para-
colpium and uterosacral and cardinal ligaments demon-
strates that these structures have a different composition
when compared to the vaginal tissue. Also, variation in
biochemical tests that are used for the analysis of vaginal/
pelvic tissues in women with POP and the heterogeneity in
the populations studied contribute to the inconsistency of
the results in the literature on connective tissue components
of vaginal/pelvic tissue in relation to POP [53].
Noteworthy is the way in which collagen and elastin are
measured: through mRNA, precursor protein or mature
levels of collagen or elastin. Measuring mRNA that still
needs to be translated and will undergo further posttrans-
lational modification and turnover will not reflect the
resulting levels of mature elastin protein. Also, the amount
of precursor protein may not reflect the actual amount of
mature collagen or elastin [48, 53]. With respect to studies
on MMP, the focus should not only be on pro-MMP or
MMP mRNA but on the entire expression profile [48, 49].
Summery and perspective
In 1996, Jackson formulated his theory about the patho-
genesis of POP [13]. He postulated that in young patients
with POP, a higher turnover of immature collagen [11]
resulted in a bulk of deficient glycated old collagen that is
difficult to degrade. This glycated collagen, which is brittle
and susceptible to rupture, may result in POP. Despite
numerous shortcomings in the available literature, the
hypothesis of Jackson [13] still appears to be valid [11,
38–41, 47, 49, 50, 82, 83].
In prolapsed tissue, the fibroblasts exhibit more collagen
production, an increased MMP-2 and MMP-9 activity and a
decrease of the activity of TIMP-1, resulting in an increased
turnover of collagen. In particular, the breakdown of
immature newly formed collagen is increased. The total
collagen content is generally lower in POP patients compared
with non-POP patients. The content of AGEs is increased in
patients with POP, which makes them susceptible for
developing POP over time.
Jackson [13] found no change in the type I to type III
ratio. Most studies, however, found an increase in type III
[41, 42, 58, 83] and/or a decrease in type I [11, 38, 40], thus
resulting in a decreased I/III ratio. An increase in the
expression of both collagen type III and MMP-9 expression
is typical of tissue that is remodelling after injury [84] or
accommodating to a progressively increasing mechanical
load [44, 85]. In particular, an increase in MMP-9 specifi-
cally in women with POP found by Jackson and confirmed
by Moalli [41] has been associated with tissue remodelling in
bone [86], coronary artery [87] and healing dermal wounds
[88].
Parity is the strongest factor in the development of POP,
with an adjusted relative risk of 10.85 (95% CI 4.65–33.81)
[5]. During childbirth, neuromuscular damage occurs. It is
not only direct injury to the levator ani muscle resulting in
mechanical disruption of the entire muscle but also damage
to the nerve supply of the muscle that could lead to their
inability to contract, even though the muscles remain intact
[89, 90]. When the pelvic floor muscles relax or are
damaged, the genital hiatus opens and the pelvic organs
must be held in place by the suspensory ligaments. Although
the ligaments can sustain these loads for short periods of
time, the connective tissues will stretch and eventually fail if
470 Int Urogynecol J (2009) 20:461–474
the pelvic floor muscles do not close the pelvic floor in time.
Physiological aging and menopause are decompensating
factors in this process [91]. It is therefore likely that after an
injury such as childbirth, the supporting connective tissue
of the vaginal wall will remodel in order to adapt to the
tensile stress. It is hard, if not impossible, to determine
whether the changes seen in collagen metabolism in women
with POP do reflect the cause or the effect of prolapse.
Alternatively, it may well be that POP is related to abnormal
repair of the injured tissue after the stress of delivery [92]. In
either case, the increased flexibility, dispensability and
decreased tensile strength associated with an increase in
collagen III, together with a decrease in elastin levels, will
very likely contribute to the progression of POP. Whether
the change in biomechanical properties is also caused by a
change in the concentration of intermolecular cross-linking
analysed in only two studies [11, 47], which both support
the findings of Jackson, may need further studies in order to
be able to substantiate this conclusion.
In future studies, a better comparison requires stand-
ardisation of biopsy sites with histological confirmation.
Also, standardisation of complementary and confirmatory
methods of protein quantification is obligatory.
More knowledge is needed about the roles of the
different types of collagen, collagen turnover and break-
down, as well as the interaction between collagen mainte-
nance, elastin metabolism, genetic components and parity
in the pathophysiology of POP. Also, information about the
intrinsic quality of the collagens, collagen cross-linking and
the mechanisms by which collagen production and break-
down are out of balance in POP patients is, in general, still
lacking. It may be postulated that most conclusive answers
will be obtained from young POP patients, in which the
genetic component may be expected to be more pro-
nounced compared to older POP patients.
The focus of research should also be on the mechanism
of fibroblasts reacting on mechanical loading, typing of the
collagens produced by fibroblasts and MMP production by
fibroblasts in POP and non-POP patients. This is of
particular interest when patients’ own stem cells are used
as a therapeutic means to restore the collagen homeostasis.
Stem cells have been used to create striated sphincter muscle
in vitro [93]. Also, autologous myoblasts and fibroblasts were
injected lateral from the urethra to treat urinary incontinence
[94–95]. Ideally, it should be possible to develop a
biocompatible and bioresorbable scaffold with appropriate
mechanical properties in which stem cells are able to
contribute to tissue regeneration by proliferation and differ-
entiation into (myo)fibroblasts and by formation of the
appropriate connective tissue. If, however, autologous fibro-
blasts of POP patients are unable to produce a good quality
extracellular matrix due to their genetic background, the use
of allogenic stem cells could be considered.
Conclusion
Recent literature data support the hypothesis of Jackson
formulated in 1996—more brittle collagen in pelvic floor
connective tissue that is difficult to degrade in POP patients
compared to non-POP patients—but do not resolve long-
standing questions on the aetiology of POP.
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